Nine building blocks the body cannot make, taken as free-form supplements to signal muscle building and repair. The best-supported effect is a short-term boost in muscle building, with modest strength and function gains when paired with resistance training — most useful for older adults, people losing weight, and those who struggle to eat enough protein. Long-term aging trade-offs stay unresolved. (Full Review)

Protocol

Standard Dose

6–15 g per serving

Complete blend with ~2.5–3 g leucine; response plateaus around 15–18 g

Timing

Peri-workout

Around resistance training and at the first meal

Distribution

Split doses

One dose per eating occasion or around training, not one large bolus

Time to effect

Muscle Synthesis

Within 1 hour

Acute rise in muscle protein synthesis after a dose

Strength & Lean Mass

Weeks–months

Consistent use combined with resistance training

Blood Peak

30–60 min

Subsides over 2–3 hours

Benefits

High: Stimulates muscle protein synthesis; preserves muscle strength in aging and sarcopenia

Medium: Improves physical performance and function in older adults; attenuates muscle loss during caloric deficit; enhances recovery from exercise-induced muscle damage

Low: Supports surgical and wound recovery

Speculative: Healthspan support through muscle preservation; cognitive and mood support via neurotransmitter precursors

Contraindications

Phenylketonuria

Maple syrup urine disease

Key Interactions

Levodopa (Parkinson's medication)

Antidiabetic drugs (metformin, insulin, sulfonylureas)

Serotonergic medications (SSRIs, MAO inhibitors, triptans)

Protein powders and amino acid supplements (whey, casein, BCAAs, collagen)

Leucine and HMB products

Chronic kidney disease (Stage 4–5, eGFR <30)

Advanced liver disease (Child-Pugh Class C)

Risk & Side Effects

High: Gastrointestinal intolerance at higher doses; harm in inborn errors of amino acid metabolism

Medium: Blood sugar and insulin resistance signals; renal burden in pre-existing kidney disease; elevated ammonia in advanced liver disease

Low: Interference with levodopa absorption; serotonergic effects from tryptophan

Speculative: Chronic growth-pathway activation and longevity trade-off; hypothesized contribution to neurodegenerative processes

Monitoring

Marker	Target	Why
eGFR	≥ 90 mL/min/1.73m²	Confirms kidneys can handle added amino acid load
BUN	~10–18 mg/dL	Tracks nitrogen waste from protein/amino acid intake
Fasting glucose	75–90 mg/dL	Screens for glucose dysregulation linked to branched-chain amino acids
HbA1c	< 5.4%	Detects longer-term glucose impact
ALT	< 25 U/L (men), < 20 U/L (women)	Confirms liver can process amino acid load
Fasting insulin	2–5 µIU/mL	Flags insulin resistance relevant to the metabolic risk debate
Plasma branched-chain amino acids	Mid-normal, not elevated	Contextualizes the insulin-resistance association

Cadence: Recheck at 8–12 weeks after starting sustained use, then every 6–12 months; more frequent with kidney, liver, or glucose concerns.

Qualitative Assessment

Strength and performance (grip strength, ability to rise from a chair, training loads)
Lean mass or muscle appearance over months
Recovery quality and reduced post-exercise soreness
Energy and daily physical function
Digestive tolerance of the chosen dose

Essential Amino Acids for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment